Regulatory Expertise Target Hurley’s strong regulatory submission capabilities (eCTD, CDISC, IND through NDA) to offer end-to-end regulatory strategy optimization and outsourced submission support for biotech and pharma clients seeking faster market access.

End-to-End Services Leverage their integrated offerings from nonclinical to manufacturing control evaluations, data analysis, and regulatory strategy to position as a single-source partner for product development programs, reducing client coordination effort.

Global Experience Highlight international project experience and 25+ years in health sciences consulting to win clients with cross-border regulatory needs, especially those navigating complex global submissions.

Mid-Sized Advantage With 11-50 employees, pitch for flexible, hands-on consulting and rapid engagement timelines that larger firms may not match, appealing to mid-stage companies and niche sponsors seeking personalized attention.

Financial Footprint Revenue range of $25M–$50M signals established operations and scalable capacity to take on additional regulatory submissions, data analyses, and dossier preparation for expanding product portfolios.